featured
Benefit of Pazopanib in Neuroendocrine Tumors
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Annals of Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Pazopanib in Pretreated Advanced Neuroendocrine Tumors: A Phase 2, Open-Label Trial of the Spanish Task Force Group for Neuroendocrine Tumors (GETNE)
Ann. Oncol 2015 Sep 01;26(9)1987-1993, E Grande, J Capdevila, D Castellano, A Teulé, I Durán, J Fuster, I Sevilla, P Escudero, J Sastre, J García-Donas, O Casanovas, J Earl, L Ortega, M Apellaniz-Ruiz, C Rodriguez-Antona, T Alonso-Gordoa, JJ Díez, A Carrato, R García-CarboneroFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.